Key result
Lower vitamin D in HIV patients links to ~11-fold higher odds of above-median CCA IMT.
Why the study?
Is vitamin D status associated with carotid intima-media thickness and immune reconstitution in HIV-positive patients on antiretroviral therapy?
Population
149 HIV-positive patients on antiretroviral therapy (56 with carotid IMT measured) and 34 healthy controls
Comparison
Vitamin D status vs Healthy controls and lower vs. higher vitamin D…
Design
Cross-sectional
Authors
Loading...
Supports vitamin D–cIMT link in treated HIV; hypothesis-generating and should not yet change practice.
Cross-Sectional (n=183)
Is vitamin D status associated with carotid intima-media thickness and immune reconstitution in HIV-positive patients on antiretroviral therapy?
Odds Ratio: 10.62 (95% CI 1.37–82.34)
p-value: p=<0.01
Lower vitamin D levels in HIV-positive patients on antiretroviral therapy are associated with increased carotid intima-media thickness and poorer immune reconstitution, suggesting a potential role in HIV-related cardiovascular disease.
Ross et al. (2010) conducted a cross-sectional in HIV infection (n=183). Lower 25-hydroxyvitamin D levels vs. Higher 25-hydroxyvitamin D levels was evaluated on Common carotid artery intima-media thickness above the median (OR 10.62, 95% CI 1.37-82.34, p=<0.01). Lower vitamin D levels in HIV-positive patients were associated with higher odds of common carotid artery intima-media thickness above the median (OR 10.62; 95% CI 1.37-82.34; P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: